Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Coeptis Therapeutics Holdings (COEP) EPS (Weighted Average and Diluted) (2022 - 2025)

Historic EPS (Weighted Average and Diluted) for Coeptis Therapeutics Holdings (COEP) over the last 4 years, with Q3 2025 value amounting to -$0.61.

  • Coeptis Therapeutics Holdings' EPS (Weighted Average and Diluted) fell 122962.48% to -$0.61 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.61, marking a year-over-year decrease of 10925.22%. This contributed to the annual value of -$5.65 for FY2024, which is 6586.39% up from last year.
  • According to the latest figures from Q3 2025, Coeptis Therapeutics Holdings' EPS (Weighted Average and Diluted) is -$0.61, which was down 122962.48% from -$1.17 recorded in Q2 2025.
  • Coeptis Therapeutics Holdings' EPS (Weighted Average and Diluted)'s 5-year high stood at -$0.05 during Q3 2024, with a 5-year trough of -$2.92 in Q4 2023.
  • For the 4-year period, Coeptis Therapeutics Holdings' EPS (Weighted Average and Diluted) averaged around -$0.75, with its median value being -$0.42 (2022).
  • As far as peak fluctuations go, Coeptis Therapeutics Holdings' EPS (Weighted Average and Diluted) soared by 8085.62% in 2024, and later plummeted by 134735.22% in 2025.
  • Over the past 4 years, Coeptis Therapeutics Holdings' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.21 in 2022, then crashed by 1320.24% to -$2.92 in 2023, then soared by 46.48% to -$1.56 in 2024, then skyrocketed by 60.96% to -$0.61 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at -$0.61 for Q3 2025, versus -$1.17 for Q2 2025 and -$1.11 for Q1 2025.